|
Non-Hodgkin's lymphoma facts
|
Non-Hodgkin's lymphoma facts- Non-Hodgkin's lymphoma is a cancer
that begins in the lymphatic system, which is part of the body's
immune system. In the lymphatic system, lymph vessels carry fluid to
lymph nodes in the neck, underarms, chest, abdomen and groin, and to
tissue in the tonsils, spleen, thymus, stomach, skin and small
intestine.- Non-Hodgkin's lymphoma begins when a lymphocyte (a B cell
or T cell) becomes abnormal and makes copies of itself. The abnormal
cells are cancer cells that...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Researcher at University of Pittsburgh Receives Funding to Pursue New Treatments and Cures for Lymphoma
U.S. Newswire
; NEW YORK, May 3 /U.S. Newswire/ -- Today the Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization, announced $1.3 million in new research grants to eight leading research institutions throughout the U.S. Lymphoma is the most common blood cancer and
|
 "Daily News (Los Angeles, CA)")
|
Q&A : ADVICE FROM EXPERTS LYMPHOMA, THOUGH RAPIDLY RISING, REMAINS OBSCURE.(L.A. LIFE)
Daily News (Los Angeles, CA)
; In 1997, lymphoma, a type of cancer, will claim the lives of more than 40,000 men, women and children in America, according to the Los Angeles-based Lymphoma Research Foundation of America. And although lymphoma is the third most rapidly rising cancer in this country, the disease remains obscure to
|
 "The Independent on Saturday (South Africa)")
|
Getting lymphoma to lump it; How early diagnosis helped stars beat cancer.(News)
The Independent on Saturday (South Africa)
; ... tests. A few days later the doctor called my mother with the bad news that it was Hodgkin's Lymphoma. My mom called me into the lounge ... everything from blood and bone marrow to a liver biopsy, the good news was that everything else in Perkins's body was clear. The prescription ...
|
|
|
Three Boston-Area Researchers Receive Funding to Pursue New Treatments and Cures for Lymphoma
U.S. Newswire
; NEW YORK, May 3 /U.S. Newswire/ -- Today the Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization, announced $1.3 million in new research grants to eight leading research institutions throughout the U.S. Lymphoma is the most common blood cancer and
|
|
|
Researcher at Tulane University Receives Funding to Pursue New Treatments and Cures for Lymphoma
U.S. Newswire
; NEW YORK, May 3 /U.S. Newswire/ -- Today the Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization, announced $1.3 million in new research grants to eight leading research institutions throughout the U.S. Lymphoma is the most common blood cancer and
|
|
|
Researchers at Stanford and UCLA Receive Funding to Pursue New Treatments and Cures for Lymphoma
U.S. Newswire
; NEW YORK, May 3 /U.S. Newswire/ -- Today the Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization, announced $1.3 million in new research grants to eight leading research institutions throughout the U.S. Lymphoma is the most common blood cancer and
|
|
|
Researcher at Rockefeller University Receives Funding to Pursue New Treatments and Cures for Lymphoma
U.S. Newswire
; NEW YORK, May 3 /U.S. Newswire/ -- Today the Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization, announced $1.3 million in new research grants to eight leading research institutions throughout the U.S. Lymphoma is the most common blood cancer and
|
|
|
Researcher at Fred Hutchinson Cancer Research Center Receives Grant Award to Pursue New Treatments and Cures for Lymphoma
U.S. Newswire
; NEW YORK, May 3 /U.S. Newswire/ -- Today the Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization, announced $1.3 million in new research grants to eight leading research institutions throughout the U.S. Lymphoma is the most common blood cancer and
|
|
Conventional treatments for non-Hodgkin's lymphoma: The need for new therapies
The Journal of Nuclear Medicine
; The purpose of this article is to review the management of nonHodgkin's lymphoma (NHL) from diagnosis through treatment, with a focus on some of the newer and highly promising treatments. Methods: The current treatment of low-grade NHL is discussed from the oncologist's perspective for the purpose
|
|
Lymphoma on rise in U.S.
The Milwaukee Journal Sentinel
; ... to find what's behind this cancer's march. But there is good news: Doctors are testing highly promising new immunotherapies for ... function has scientists considering a lymphoma link. But the big news is in experimental immunotherapy -- genetically engineering cells ...
|